DE2052131A1 - Präparat - Google Patents

Präparat

Info

Publication number
DE2052131A1
DE2052131A1 DE19702052131 DE2052131A DE2052131A1 DE 2052131 A1 DE2052131 A1 DE 2052131A1 DE 19702052131 DE19702052131 DE 19702052131 DE 2052131 A DE2052131 A DE 2052131A DE 2052131 A1 DE2052131 A1 DE 2052131A1
Authority
DE
Germany
Prior art keywords
acid
garcinic
lactone
derivative
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702052131
Other languages
German (de)
English (en)
Inventor
John M Wellesley Hills Mass Lowenstein (V St A )
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2052131A1 publication Critical patent/DE2052131A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19702052131 1969-10-29 1970-10-23 Präparat Pending DE2052131A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87241369A 1969-10-29 1969-10-29

Publications (1)

Publication Number Publication Date
DE2052131A1 true DE2052131A1 (de) 1971-05-06

Family

ID=25359519

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702052131 Pending DE2052131A1 (de) 1969-10-29 1970-10-23 Präparat

Country Status (9)

Country Link
BE (1) BE758122A (enExample)
CA (1) CA923425A (enExample)
DE (1) DE2052131A1 (enExample)
FR (1) FR2070174B1 (enExample)
GB (1) GB1311015A (enExample)
IE (1) IE34648B1 (enExample)
IL (1) IL35477A (enExample)
NL (1) NL7015348A (enExample)
ZA (1) ZA706931B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716374A1 (fr) * 1994-02-18 1995-08-25 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
EP0787489A3 (enExample) * 1995-12-15 1997-09-10 Sigma Tau Ind Farmaceuti

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792180A (fr) * 1971-12-02 1973-06-01 Hoffmann La Roche Derives de l'acide citrique
ES2106689B1 (es) * 1996-04-18 1998-05-16 Cabo Soler Jose Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
US20030004215A1 (en) * 2001-06-15 2003-01-02 Van Laere Katrien Maria Jozefa Dietetic preparation and method for inhibiting intestinal carbohydrate absorption

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716374A1 (fr) * 1994-02-18 1995-08-25 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
EP0787489A3 (enExample) * 1995-12-15 1997-09-10 Sigma Tau Ind Farmaceuti

Also Published As

Publication number Publication date
BE758122A (fr) 1971-04-28
NL7015348A (enExample) 1971-05-04
GB1311015A (en) 1973-03-21
IE34648B1 (en) 1975-07-09
FR2070174A1 (enExample) 1971-09-10
IL35477A (en) 1973-08-29
IL35477A0 (en) 1970-12-24
IE34648L (en) 1971-04-29
CA923425A (en) 1973-03-27
ZA706931B (en) 1971-07-28
FR2070174B1 (enExample) 1974-02-22

Similar Documents

Publication Publication Date Title
US3764692A (en) Method of treating obesity
DE68910386T2 (de) Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken.
DE2910221C2 (enExample)
DE69409969T2 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE69034181T2 (de) Kapsel, enthaltend ein Dioxabicyclo(3.3.0)oktan
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2858802C2 (de) Arzneimittel zur unterdrueckung von tumorzellwachstum
DE19653225A1 (de) Kreatin-pyruvate und Verfahren zu deren Herstellung
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
DE2141634C3 (de) Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten
DE60129032T2 (de) Creatinester-pronutrient-verbindungen und formulierungen
DE69809944T2 (de) Fettsäuren als eine nährungsergänzung
DE2052131A1 (de) Präparat
DE2625012C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2258255A1 (de) Citronensaeurederivate
DE2723876C2 (de) 17β-Ester von Testosteron
DE69320367T2 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
CH624098A5 (enExample)
CH621780A5 (enExample)
DE1593096B2 (enExample)
DE3021169C2 (de) Pivaloyloxymethyl-2-propylpentanoat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
AT395818B (de) Auf das herz-kreislauf-system wirkende arzneimittelpraeparate und verfahren zur herstellung derselben
DE2703652C2 (enExample)
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2038836C3 (de) Arzneimittel

Legal Events

Date Code Title Description
OHW Rejection